Efficacy of Different Biologics for Treating Chronic Rhinosinusitis with Nasal Polyps: a Network Meta-analysis

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2024 Aug 26

PMID 39187717

Authors

Huikang Wang

Xinjun Xu

Zhaoyang Lu

Zhaoxue Zhai

Liting Shao

Xicheng Song

Yu Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Currently, there is a debate around the use of biological agents in the treatment of chronic sinusitis with nasal polyps. Therefore, this study's purpose was to assess the effectiveness of various biologics in the treatment of chronic rhinosinusitis with nasal polyps.

Methods: A systematic and manual search was conducted for all relevant studies from inception to December 20, 2023. Two independent authors carried out the search, screening, assessment, and data extraction. Network meta-analysis was conducted using STATA 14 software.

Results: Our analysis includes a comprehensive set of 19 studies. These studies compared the efficacy of four distinct biologic treatments. The results of reticulated Meta-analysis showed that Dupilumab (MD = - 1.85, 95% CI: - 2.47, - 1.24), Omalizumab (MD = - 1.30, 95% CI: - 1.90, - 0.70), Benralizumab (MD = - 0.84, 95% CI: - 1.66, - 0.03) and Mepolizumab (MD = - 1.48, 95% CI: - 2.22, - 0.74) were superior to placebo from the nasal polyp score(NPS), Dupilumab (MD = - 12.56, 95% CI: - 22.49,- 2.63) was superior to placebo from the Sino-Nasal Outcome Test-22(SNOT-22)score, and Dupilumab (MD = - 0.84, 95% CI: - 1.08, - 0.59) and Omalizumab (RR = - 0.51, 95% CI: - 0.83, - 0.19) were superior to placebo from the nasal congestion severity(NCS). In terms of cumulative sorting under the surface of the curve (SUCRA) values, Dupilumab was the best performer in the NPS (0.92), SNOT-22 score (0.70), and NCS (0.93); Four different biologics outperformed placebo in the NPS, SNOT-22 score, and NCS.

Conclusion: In patients with CRSwNP, based on the efficacy (NPS, (SNOT-22) score, NCS) and, dupilumab is the most efficacious for CRSwNP.

Citing Articles

Biologic Treatments for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): A Comparative Review of Efficiency and Risks.

Tanase M, Tanase M, Cosgarea M, Radeanu G, Pop S, Maniu A Cureus. 2025; 17(1):e77804.

PMID: 39844880 PMC: 11751697. DOI: 10.7759/cureus.77804.

References

Fokkens W . Comparing outcomes: the KISS principle. Rhinology. 2020; 58(6):529. DOI: 10.4193/Rhin20.806. View

Wang X, Zheng M, Lou H, Wang C, Zhang Y, Bo M . An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016; 71(8):1170-80. PMC: 5074323. DOI: 10.1111/all.12874. View

Yao Y, Liu Z, Ji J, Jiao Q . Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis. J Allergy Clin Immunol Glob. 2024; 3(2):100222. PMC: 10899057. DOI: 10.1016/j.jacig.2024.100222. View

Caid K, Tate M, Yousuf S, Jones L, Pesek R, Jefferson A . Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections. J Allergy Clin Immunol Glob. 2024; 3(4):100340. PMC: 11533078. DOI: 10.1016/j.jacig.2024.100340. View

Min H, Kim K, Kim H, Gong J, Jeong J . Identification and characterization of microplastics in human nasal samples. Int Forum Allergy Rhinol. 2024; 14(12):1943-1946. PMC: 11610425. DOI: 10.1002/alr.23427. View

Behnke J, Dundervill C, Al-Asadi Z, Shahid M, Ramadan H, Makary C . Gender Differences in Adults With Chronic Rhinosinusitis: A Scoping Review. Otolaryngol Head Neck Surg. 2024; 170(6):1659-1667. DOI: 10.1002/ohn.663. View

Hong H, Chen T, Yang Q, Sun Y, Chen F, Lou H . Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). ORL J Otorhinolaryngol Relat Spec. 2023; 85(3):128-140. DOI: 10.1159/000529918. View

Cergan R, Berghi O, Dumitru M, Vrinceanu D, Manole F, Serboiu C . Biologics for Chronic Rhinosinusitis-A Modern Option for Therapy. Life (Basel). 2023; 13(11). PMC: 10672088. DOI: 10.3390/life13112165. View

Bai J, Tan B, Kato A . Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2023; 24(1):1-8. PMC: 10873077. DOI: 10.1097/ACI.0000000000000954. View

Kato A, Peters A, Stevens W, Schleimer R, Tan B, Kern R . Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2021; 77(3):812-826. PMC: 9148187. DOI: 10.1111/all.15074. View

10.

Tsuda T, Suzuki M, Kato Y, Kidoguchi M, Kumai T, Fujieda S . The current findings in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx. 2023; 51(1):51-60. DOI: 10.1016/j.anl.2023.08.002. View

11.

Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H . Diversity of T cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016; 138(5):1344-1353. DOI: 10.1016/j.jaci.2016.05.041. View

12.

Guo C, Liu F, Wang D, Liu Z . Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP. Curr Allergy Asthma Rep. 2023; 23(12):703-713. DOI: 10.1007/s11882-023-01114-w. View

13.

Huang Y, Zhang N, Bachert C . Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps. Expert Rev Clin Immunol. 2023; 19(8):837-845. DOI: 10.1080/1744666X.2023.2206120. View

14.

Haloob N, Karamali K, Hopkins C . The Role of Biologics in the Treatment of Chronic Rhinosinusitis. BioDrugs. 2023; 37(4):477-487. DOI: 10.1007/s40259-023-00602-9. View

15.

Kim S, Cho K . Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence. Int J Mol Sci. 2023; 24(5). PMC: 10002552. DOI: 10.3390/ijms24055015. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Hutton B, Salanti G, Caldwell D, Chaimani A, Schmid C, Cameron C . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015; 162(11):777-84. DOI: 10.7326/M14-2385. View

18.

Cumpston M, Li T, Page M, Chandler J, Welch V, Higgins J . Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019; 10:ED000142. PMC: 10284251. DOI: 10.1002/14651858.ED000142. View

19.

Fahmy O, Fahmy U, Alhakamy N, Khairul-Asri M . Single-Port versus Multiple-Port Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis. J Clin Med. 2021; 10(24). PMC: 8703720. DOI: 10.3390/jcm10245723. View